Rafael Campo

2.5k total citations · 1 hit paper
50 papers, 1.5k citations indexed

About

Rafael Campo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Rafael Campo has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 13 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Rafael Campo's work include HIV/AIDS Research and Interventions (17 papers), HIV/AIDS drug development and treatment (16 papers) and HIV Research and Treatment (13 papers). Rafael Campo is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV/AIDS drug development and treatment (16 papers) and HIV Research and Treatment (13 papers). Rafael Campo collaborates with scholars based in United States, United Kingdom and Spain. Rafael Campo's co-authors include Brian Gazzard, José Ramón Arribas, Andrew Cheng, Damian J. McColl, Joel E. Gallant, Edwin DeJesus, Anton Pozniak, John J. Toole, Jeffrey Enejosa and Biao Lu and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Rafael Campo

44 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

2006 703 citations Joel E. Gallant, Edwin DeJesus et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafael Campo United States	14	1.2k	814	413	304	84	50	1.5k
Mauro Zaccarelli Italy	25	1.2k 1.0×	953 1.2×	218 0.5×	498 1.6×	66 0.8×	91	1.7k
Jonathan Ainsworth United Kingdom	18	792 0.6×	515 0.6×	236 0.6×	492 1.6×	50 0.6×	44	1.2k
Linda Aurpibul Thailand	19	807 0.7×	495 0.6×	433 1.0×	385 1.3×	101 1.2×	89	1.3k
Réjean Thomas Canada	22	1.2k 1.0×	929 1.1×	170 0.4×	656 2.2×	49 0.6×	84	1.8k
James Hellinger United States	19	1.4k 1.1×	819 1.0×	329 0.8×	741 2.4×	80 1.0×	30	1.8k
Diego Ripamonti Italy	21	969 0.8×	630 0.8×	330 0.8×	358 1.2×	61 0.7×	62	1.2k
Kenneth Tapia United States	23	857 0.7×	478 0.6×	141 0.3×	495 1.6×	112 1.3×	57	1.3k
Sara Madge United Kingdom	16	889 0.7×	545 0.7×	292 0.7×	433 1.4×	37 0.4×	34	1.2k
Barry S. Zingman United States	20	985 0.8×	438 0.5×	345 0.8×	652 2.1×	128 1.5×	57	1.6k
Tammy Meyers South Africa	27	1.4k 1.2×	918 1.1×	272 0.7×	495 1.6×	60 0.7×	52	1.8k

Countries citing papers authored by Rafael Campo

Since Specialization

Citations

This map shows the geographic impact of Rafael Campo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Campo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Campo more than expected).

Fields of papers citing papers by Rafael Campo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Campo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Campo. The network helps show where Rafael Campo may publish in the future.

Co-authorship network of co-authors of Rafael Campo

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Campo. A scholar is included among the top collaborators of Rafael Campo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Campo. Rafael Campo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wohl, David A., John R. Koethe, Paul E. Sax, et al.. (2024). Antiretrovirals and Weight Change: Weighing the Evidence. Clinical Infectious Diseases. 79(4). 999–1005. 15 indexed citations

Campo, Rafael. (2023). Illness Metaphors and COVID-19. JAMA. 329(12). 1035–1035. 1 indexed citations

Pretell‐Mazzini, Juan, Ty K. Subhawong, Victor H. Hernandez, & Rafael Campo. (2016). HIV and Orthopaedics. Journal of Bone and Joint Surgery. 98(9). 775–786. 10 indexed citations

Iacobellis, Gianluca, et al.. (2014). Predictors of Short-Term Diabetes Remission After Laparoscopic Roux-en-Y Gastric Bypass. Obesity Surgery. 25(5). 782–787. 12 indexed citations

Squires, Kathleen, Linda‐Gail Bekker, Joseph J. Eron, et al.. (2013). Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study. AIDS Research and Human Retroviruses. 29(6). 859–870. 16 indexed citations

Campo, Rafael, Barbara A. da Silva, Laurent Cotte, et al.. (2009). Predictors of Loss of Virologic Response in Subjects Who Simplified to Lopinavir/Ritonavir Monotherapy from Lopinavir/Ritonavir Plus Zidovudine/Lamivudine. AIDS Research and Human Retroviruses. 25(3). 269–275. 14 indexed citations

Campo, Rafael. (2007). The Enemy.

Campo, Rafael, S Narayanan, Patrick G. Clay, et al.. (2007). Factors Influencing the Acceptance of Changes in Antiretroviral Therapy among HIV-1–Infected Patients. AIDS Patient Care and STDs. 21(5). 329–338. 6 indexed citations

Campo, Rafael. (2006). Why Should Medical Students Be Writing Poems?. Journal of Medical Humanities. 27(4). 253–254. 4 indexed citations

10.

Pozniak, Anton, Joel E. Gallant, Edwin DeJesus, et al.. (2006). Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(5). 535–540. 184 indexed citations

11.

Campo, Rafael, et al.. (2005). Differences in Presentation and Outcome of Invasive Pneumococcal Disease among Patients with and without HIV Infection in the Pre-HAART Era. AIDS Patient Care and STDs. 19(3). 141–149. 12 indexed citations

12.

Campo, Rafael, et al.. (2005). Antiretroviral Treatment Considerations in Latino Patients. AIDS Patient Care and STDs. 19(6). 366–374. 15 indexed citations

13.

Parada, Jorge P., Maria Deloria Knoll, Joan S. Chmiel, et al.. (2004). HIV-Related Pneumonia Care in Older Patients Hospitalized in the Early HAART Era. AIDS Patient Care and STDs. 18(2). 99–107. 8 indexed citations

14.

Campo, Rafael, et al.. (2004). Effectiveness and tolerability of a once‐daily amprenavir/ritonavir‐containing highly active antiretroviral therapy regimen in antiretroviral‐naïve patients at risk for nonadherence: 48‐week results after 24 weeks of directly observed therapy. HIV Medicine. 5(5). 364–370. 5 indexed citations

15.

Parada, Jorge P., Maria Deloria Knoll, Joan S. Chmiel, et al.. (2003). Relationship between Health Insurance and Medical Care for Patients Hospitalized with Human Immunodeficiency Virus--Related Pneumocystis carinii Pneumonia, 1995-1997: Medicaid, Bronchoscopy, and Survival. Clinical Infectious Diseases. 37(11). 1549–1555. 6 indexed citations

16.

Campo, Rafael, et al.. (2003). Effect of Class-Specific Therapy Interruption on Persistence of HIV Type 1 Antiretroviral Resistance. AIDS Research and Human Retroviruses. 19(8). 653–656. 8 indexed citations

17.

Kim, Benjamin, Jorge P. Parada, Constance R. Uphold, et al.. (2001). HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. Journal of General Internal Medicine. 16(9). 583–589. 12 indexed citations

18.

Campo, Rafael, et al.. (1997). Mycobacterium kansasiiDisease in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 24(6). 1233–1238. 47 indexed citations

19.

Campo, Rafael, D. R. Schultz, & A L Bisno. (1995). M Proteins Of Group G Streptococci: Mechanisms Of Resistance To Phagocytosis. The Journal of Infectious Diseases. 171(3). 601–606. 25 indexed citations

20.

Campo, Rafael, Kenneth R. Ratzan, & Steven J. Melnick. (1994). Subcutaneous Nodules as a Dermatologic Manifestation of Bacteremia Due to Pseudomonas aeruginosa. Southern Medical Journal. 87(2). 233–235. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact